NCT03611868 · Interventional trial
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
Overall registry status Active not recruiting
Phase 1 · Phase 2
Conditions Cutaneous Melanoma, MDM2 Gene Mutation, Malignant Peripheral Nerve Sheath Tumors (MPNST), Melanoma, Mucosal Melanoma, P53 Mutation, Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Uveal Melanoma
Delaware Valley sites
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory